Zobrazeno 1 - 10
of 113
pro vyhledávání: '"E Pelz"'
Publikováno v:
Online Learning, Vol 7, Iss 2 (2019)
This paper is a follow-up study to a preliminary investigation of teaching presence in the State University of New York Learning Network (SLN). In the present studywe review ongoing issues of pedagogy and faculty development, and their relationship t
Externí odkaz:
https://doaj.org/article/4d242f52fabe4df692af00be15cbc9a8
Autor:
M. Graeser, N. Harbeck, O. Gluz, U.A. Nitz, M. Christgen, S. Kuemmel, E-M. Grischke, H. Forstbauer, M. Braun, M. Warm, J.C. Hackmann, C. Uleer, B. Aktas, R. Würstlein, E. Pelz, C. Zu Eulenburg, H. Kreipe, M. Trau, C. Stirzaker, D. Korbie
Publikováno v:
ESMO Open. 8:101242
Autor:
Bassett, Lawrence J, Stephen E. Pelz
Publikováno v:
The SHAFR Guide Online
Externí odkaz:
https://doi.org/10.1163/2468-1733_shafr_SIM170110003
Publikováno v:
Scientific Annals of Computer Science, Vol XX, Pp 131-157 (2010)
Automated verification of dynamic multi-threaded computing systems is severely affected by problems relating to dynamic process creation. In this paper, we describe an abstraction technique aimed at generating reduced state space representations for
Externí odkaz:
https://doaj.org/article/99d7b9fb52164f6d9103e70066522e53
Autor:
Ronald E. Kates, Cornelia Kolberg-Liedtke, Nadia Harbeck, Tanja Fehm, Oleg Gluz, Elena Bensmann, Monika Ortmann, Florian Heitz, Andreas du Bois, Muriel Freudenberger, E Pelz, Elena Sultova, Rachel Wuerstlein, M. Warm, Ulrike Nitz, Sara Y. Brucker
Publikováno v:
Breast Care (Basel)
Introduction: Tumor biological factors of breast cancer (BC) such as hormone receptor (HR) status, HER2 status, and grade can differ in the metastatic cascade from primary to lymph node (LN) metastasis and to distant metastatic tissue. Systematic dat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::911e97e0649a6bc0973ac6b09820e124
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85098158631
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85098158631
Autor:
Daniel Gebauer, Aleix Prat, M. Warm, Matthias Christgen, Cornelia Liedtke, Laia Paré, E Pelz, S. Kuemmel, U. Nitz, R Kates, Petra Krabisch, Bahriye Aktas, Michael R. Clemens, Rachel Wuerstlein, H.H. Kreipe, Nadia Harbeck, O Gluz
Publikováno v:
Cancer Research. 78:P2-10
Background: Optimal treatment, particularly use of anthracyclines in aggressive triple-negative breast cancer (TNBC), is still a controversial issue in early BC management. However, TNBC exhibits substantial molecular heterogeneity: for example, the
Autor:
Hans Kreipe, Maximilian Schieck, Brigitte Schlegelberger, S Kundu, Florian Länger, E Pelz, Doris Steinemann, Stefanie Pertschy, Matthias Christgen, Stephan Bartels, Ulrich Lehmann, Bjoern Sander, Jana Lisa van Luttikhuizen
Publikováno v:
The Journal of Pathology: Clinical Research. 3:191-202
Recently, a new variant of invasive lobular breast cancer (ILBC) with solid-papillary-like growth pattern has been described. We present a case of ILBC with solid-papillary-like growth pattern in the main tumour mass and classical invasive lobular gr
Autor:
MP Lux, A Hartmann, Albrecht Stenzinger, Peter Sinn, Rainer Kimmig, O Hoffmann, Robert Fred Henry Walter, D Ulbrich-Gebauer, E Pelz, Nadia Harbeck, T. Kirchner, Rachel Würstlein, Agnes Bankfalvi, R Stöhr, Marius Wunderle, Martina Vetter, Karl Sotlar, C. Thomssen, Doris Mayr, R Erber, PA Fasching, K.W. Schmid, MW Beckmann
Publikováno v:
Senologie - Zeitschrift für Mammadiagnostik und -therapie. 14:A1-A53
Publikováno v:
Breast care (Basel, Switzerland). 13(6)
Granulomatous mastitis (GM) is a rare benign inflammatory breast disease that affects mostly women of childbearing age with a history of breastfeeding. The etiopathogenesis is still unknown; however, inflammation as the result of a reaction to trauma
Autor:
Katja Krauss, E Pelz, Hans Holger Fischer, Hans Kreipe, Nadia Harbeck, Matthias Christgen, Eva-Maria Grischke, Rachel Wuerstlein, Oleg Gluz, Jochem Potenberg, S. Kuemmel, Toralf Reimer, Helmut Forstbauer, Monika Graeser, Christine Eulenburg, Ulrike Nitz, Michael Braun, Claudia Schumacher, Andrea Stefek, Ronald E. Kates
Publikováno v:
Journal of Clinical Oncology. 39:503-503
503 Background: Optimal use of de-escalated, particularly chemotherapy(CT)-free, neoadjuvant regimens in HER2+ early breast cancer (EBC) is currently unclear as there are limited survival data so far. In ADAPT-HR-/HER2+, we previously showed an excel